Table 3.
Final model of MOVE! utilization among obese patients treated in the veterans health administration (FY 2010) a (N=1,742,937)
| OR [95% CI] | P | |
|---|---|---|
|
Age (ref.: <40 years old) |
|
|
| 40–49 |
1.21 [ 1.17, 1.25 ] |
<.001*** |
| 50–59 |
1.25 [ 1.21 , 1.28 ] |
<.001*** |
| 60–69 |
1.24 [ 1.20 , 1.28 ] |
<.001*** |
| 70–79 |
0.45 [ 0.44 , 0.47 ] |
<.001*** |
| 80+ |
0.18 [ 0.17 , 0.20 ] |
<.001*** |
|
Female gender |
1.66 [ 1.62 , 1.70 ] |
<.001*** |
|
Married |
0.94 [ 0.93 , 0.95] |
<.001*** |
|
Minority racial status |
1.36 [ 1.34 , 1.39 ] |
<.001*** |
|
BMI (ref.: Overwt [<30 BMI]) |
|
|
| Class I (30–34 BMI) |
1.47 [ 1.44, 1.51] |
<.001*** |
| Class II (35–39 BMI) |
2.67 [ 2.61 , 2.73 ] |
<.001*** |
| Class III (40+ BMI) |
4.54 [ 4.43 , 4.56 ] |
<.001*** |
|
Home instability |
1.63 [ 1.57 , 1.68 ] |
<.001*** |
|
Outpatient copay |
1.57 [ 1.35 , 1.83] |
<.001*** |
|
Geographic location (reference: Highly Rural) |
|
<.001*** |
| Rural |
0.95 [ 0.82 , 1.09 ] |
.46 |
| Urban |
1.17 [ 1.15 , 1.19] |
.02* |
|
Obesity comorbidity |
1.68 [ 1.64 , 1.73 ] |
<.001*** |
|
Obesogenic psychiatric drug |
1.17 [ 1.15 , 1.19 ] |
<.001*** |
|
Psychiatric diagnosis |
1.58 [ 1.55 , 1.60 ] |
<.001*** |
|
% Home instability |
1.09 [ 1.02 , 1.16 ] |
<.001*** |
|
% Obesogenic drugs |
0.92 [ 0.90 , 0.95 ] |
<.001*** |
| Intercept | 0.03 [ 0.02, 0.06 ] | <.001*** |
Note: aResults from mixed-effects logistic regression model with a random effect for facility. *p < .05, ***p < .001.